FDA — authorised 2 August 1990
- Marketing authorisation holder: GLAXOSMITHKLINE
- Status: approved
🇺🇸 L-Dipalmitoyl Lecithin in United States
FDA authorised L-Dipalmitoyl Lecithin on 2 August 1990
Marketing authorisation
L-Dipalmitoyl Lecithin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in United States
Frequently asked questions
Is L-Dipalmitoyl Lecithin approved in United States?
Yes. FDA authorised it on 2 August 1990.
Who is the marketing authorisation holder for L-Dipalmitoyl Lecithin in United States?
GLAXOSMITHKLINE holds the US marketing authorisation.